Your browser doesn't support javascript.
loading
Intracavitary 'T4 immunotherapy' of malignant mesothelioma using pan-ErbB re-targeted CAR T-cells.
Klampatsa, Astero; Achkova, Daniela Y; Davies, David M; Parente-Pereira, Ana C; Woodman, Natalie; Rosekilly, James; Osborne, Georgina; Thayaparan, Thivyan; Bille, Andrea; Sheaf, Michael; Spicer, James F; King, Juliet; Maher, John.
Afiliación
  • Klampatsa A; King's College London, Division of Cancer Studies, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK.
  • Achkova DY; King's College London, Division of Cancer Studies, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK.
  • Davies DM; King's College London, Division of Cancer Studies, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK.
  • Parente-Pereira AC; King's College London, Division of Cancer Studies, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK.
  • Woodman N; King's College London, Division of Cancer Studies, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK.
  • Rosekilly J; King's College London, Division of Cancer Studies, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK.
  • Osborne G; Department of Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Thayaparan T; King's College London, Division of Cancer Studies, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK.
  • Bille A; Department of Thoracic Surgery, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Sheaf M; Department of Histopathology, Barts Health NHS Trust, The Royal London Hospital, London E1 2ES, UK.
  • Spicer JF; King's College London, Division of Cancer Studies, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK; Department of Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • King J; Department of Thoracic Surgery, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Maher J; King's College London, Division of Cancer Studies, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK; Department of Clinical Immunology and Allergy, King's College Hospital NHS Foundation Trust, Denmark Hill, London SE5 9RS, UK; Department of Immunology, Eastbourne Hospital, Kings Drive, Eastbourn
Cancer Lett ; 393: 52-59, 2017 05 01.
Article en En | MEDLINE | ID: mdl-28223167
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pleurales / Receptores de Antígenos de Linfocitos T / Linfocitos T / Terapia Genética / Inmunoterapia Adoptiva / Linfocitos Infiltrantes de Tumor / Interleucina-4 / Receptores ErbB / Neoplasias Pulmonares / Mesotelioma Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cancer Lett Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Irlanda
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pleurales / Receptores de Antígenos de Linfocitos T / Linfocitos T / Terapia Genética / Inmunoterapia Adoptiva / Linfocitos Infiltrantes de Tumor / Interleucina-4 / Receptores ErbB / Neoplasias Pulmonares / Mesotelioma Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cancer Lett Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Irlanda